Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
PRGN-2012 by Precigen for Recurrent Respiratory Papillomatosis (Juvenile Laryngeal Papilloma or Laryngeal Papilloma): Likelihood of Approval
PRGN-2012 is under clinical development by Precigen and currently in Phase III for Recurrent Respiratory Papillomatosis (Juvenile Laryngeal Papilloma or...